Table 2.
Target | Single-photon (MBI/BSGI) | Positron-emitter (PET or PEM) |
---|---|---|
Perfusion | Tl-201 Thallous Chloride | O-15 Water |
Tc-99m Sestamibi | ||
Tc-99m tetrofosmin | ||
Glucose metabolism | Tc-99m EC-glucosamine | F-18 FDG |
Hormone receptor | I-123 estradiol | F-18 FES |
F-18 fluoro-tamoxifen | ||
F-18 fluoro-norprogesterone | ||
F-18 fluoromoxestol | ||
HER2 | In-111 trastuzumab | Zr-89 trastuzumab |
Cell proliferation/angiogenesis | Tc-99m maraciclatide | F-18 flucuclatide |
In-111 bevacizumab | F-18 galacto-RGD | |
F-18 fluorothymidine | ||
Zr-80 bevacizumab | ||
Amino acid transporters & protein synthesis | Tc-99m methionine | C-11 methionine |
I-123 methyltyrosine | C-11 tyrosine | |
F-18 fluoro-ethyl-tyrosine | ||
Epidermal growth factor receptor | C-11 Iressa | |
Cell surface receptor (VPAC1) | Tc-99m VPAC1 | Cu-64 VPAC1 |
Hypoxia | F-18 fluoromisonidazole | |
F-18 fluoroetanidazole | ||
F-18 fluoroazomycin-arabinoside | ||
Cu-64 diacetyl-bis-N4-methylthiosemicarbazone | ||
Apoptosis | Tc-99m EC-annexin V | F-18 annexin V |
Somatostatin receptors | In-111 octreotide | |
Membrane synthesis | C-11 choline |